Hcw Biologics Inc (HCWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 54 | 2,567 | 2,842 | 6,722 | 0 |
| Cost of Goods | 43 | 1,607 | 2,281 | 4,136 | 0 |
| Gross Profit | 11 | 959 | 560 | 2,586 | N/A |
| Operating Expenses | 13,217 | 31,023 | 26,559 | 17,801 | 13,368 |
| Operating Income | -13,163 | -29,457 | -25,717 | -15,079 | -13,368 |
| Interest Expense | 845 | 654 | 283 | 127 | 0 |
| Other Income | 6,048 | 87 | 1,006 | 305 | 505 |
| Pre-tax Income | -7,960 | -30,024 | -24,994 | -14,901 | -12,863 |
| Net Income Continuous | -7,960 | -30,024 | -24,994 | -14,901 | -12,863 |
| Net Income | $-7,960 | $-30,024 | $-24,994 | $-14,901 | $-12,863 |
| EPS Basic Total Ops | -10.63 | -30.96 | -28.00 | -16.80 | -27.60 |
| EPS Basic Continuous Ops | -3.79 | -30.95 | -27.83 | -16.64 | -27.41 |
| EPS Diluted Total Ops | -10.63 | -30.96 | -28.00 | -16.80 | -27.60 |
| EPS Diluted Continuous Ops | -3.79 | -30.95 | -27.83 | -16.64 | -27.41 |
| EPS Diluted Before Non-Recurring Items | N/A | -30.80 | -28.00 | -16.80 | -27.60 |
| EBITDA(a) | $-12,121 | $-28,272 | $-24,582 | $-14,361 | $-12,824 |